• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • Masitinib
      • NurOwn
      • CNM-Au8
      • ILB
      • AstroRx
      • Neuronata-R / Lenzumestrocel
      • PrimeC
      • NP001
      • Pridopidine
      • SOD1 Therapies and Trials
      • C9orf72 Therapies and Trials
      • SPG302
      • Regulatory T Cell Enhancing Therapies
      • Ulefnersen
    • Approved Drugs
      • Nuedexta
      • Radicava / Edaravone
      • Riluzole / Tiglutik
      • Rozebalamin / Methylcobalamin
      • Tofersen / Qalsody
    • Drugs No Longer in Development
      • AMX0035
      • Reldesemtiv
      • Arimoclomol
      • TUDCA
      • CuATSM
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Forbes Norris Award

The Forbes Norris Award was established in 1994 to honour the legacy of Dr. Forbes “Ted” Norris (1928–1993), a neurologist who dedicated his life to supporting people living with ALS/MND. This prestigious award recognizes individuals whose work advances clinical care, research, and understanding of ALS/MND for the benefit of those living with the disease.

To be considered for the Forbes Norris Award, candidates must:

  • Play a major role in delivering outstanding ALS/MND patient care
  • Contribute significantly to medical literature in clinical management or basic science related to ALS/MND
  • Be part of a team engaged in ongoing research into ALS/MND care, management, or basic science

The award is presented annually during the opening ceremony of the MND Association’s International Symposium on ALS/MND. If no suitable candidate is nominated in a given year, the award will not be granted. Please note that current Board of Directors are not eligible for nomination.

The 2026 nomination period is open. The deadline to submit your nominations is Tuesday, September 15.

Forbes Norris Award Nomination Form

  • (No self-nominations please)
  • Accepted file types: doc, docx, pdf, Max. file size: 128 MB.
    Please use .doc, .docx, or .pdf
  • This field is for validation purposes and should be left unchanged.

Primary Sidebar

  • H. Todd Kelly, USA

    H. Todd Kelly, USA

  • Glen Victor Peters, Australia

    Glen Victor Peters, Australia

  • Phil Rossall, UK

    Phil Rossall, UK

  • Andres Estevez Guersznik, Ireland

    Andres Estevez Guersznik, Ireland

  • Rolf Mauch, Switzerland

    Rolf Mauch, Switzerland

  • Dr. Janmejay Pradhan, India

    Dr. Janmejay Pradhan, India

  • Torben Mikkelsen, Denmark

    Torben Mikkelsen, Denmark

  • Paul Launer, USA

    Paul Launer, USA

  • Enzo Maccarrone, Italy

    Enzo Maccarrone, Italy

  • Jean

    Jean
    jean

  • Alfredo Santos, Colombia

    Alfredo Santos, Colombia

  • Chih Ching Darren Wong, Malaysia

    Chih Ching Darren Wong, Malaysia

  • Ching-Liang Chu, Taiwan

    Ching-Liang Chu, Taiwan

  • Jean Waters, UK

    Jean Waters, UK

  • Elisabeth Zahnd, Switzerland

    Elisabeth Zahnd, Switzerland

  • Rob Tison, USA

    Rob Tison, USA

  • JP

    JP

  • Brigitte Wernli, Switzerland

    Brigitte Wernli, Switzerland

  • Charlie Dourney, USA

    Charlie Dourney, USA

  • Maria Santos Garcia Tellez, Mexico

    Maria Santos Garcia Tellez, Mexico

  • Dawn Morton, Scotland

    Dawn Morton, Scotland

  • Roxana Canova, Argentina

    Roxana Canova, Argentina

  • Brian Parsons, Canada

    Brian Parsons, Canada

  • Francisco Perez Palop, Spain

    Francisco Perez Palop, Spain

  • Marcelo Farinelli, Brazil

    Marcelo Farinelli, Brazil

  • Nicholas (Nic) Bowman, South Africa

    Nicholas (Nic) Bowman, South Africa

  • Ailsa Malcolm-Hutton, UK

    Ailsa Malcolm-Hutton, UK

  • Malcolm Buck, Australia

    Malcolm Buck, Australia

  • Murat Morali, Turkey

    Murat Morali, Turkey

  • Valdomiro Xavier Honório, Brazil

    Valdomiro Xavier Honório, Brazil

  • Michel Perrozzo, France

    Michel Perrozzo, France

  • Orly Dichoso, Canada

    Orly Dichoso, Canada

  • Robbie Caliste, UK

    Robbie Caliste, UK

  • Philip Brindle, England

    Philip Brindle, England

  • Cliff Marshman, USA

    Cliff Marshman, USA
    CliffMarshman

  • Art Eggert, USA

    Art Eggert, USA

  • David Solomon, UK

    David Solomon, UK

  • Den Haag, Netherlands

    Den Haag, Netherlands

  • Joanne Pratt, Australia

    Joanne Pratt, Australia

  • Mahmood Anwar, UK

    Mahmood Anwar, UK

  • John Russo, USA

    John Russo, USA
    final3878

  • Anderson Custodio Pinto, Brazil

    Anderson Custodio Pinto, Brazil

  • Eddy Lefrancois, Canada

    Eddy Lefrancois, Canada

  • Conny van der Meijden, Netherlands

    Conny van der Meijden, Netherlands

  • Andrea Zicchieri, Italy

    Andrea Zicchieri, Italy
    AndreaZicchieri_conSLAncioItaly

  • Marcel R. Wernard, Netherlands

    Marcel R. Wernard, Netherlands

  • Carlos Gomez Matallanas, Spain

    Carlos Gomez Matallanas, Spain

  • Maria Lucia Wood Saldanha, Brazil

    Maria Lucia Wood Saldanha, Brazil

  • Kirsten Harley, Australia

    Kirsten Harley, Australia

  • Antonio Ventriglia, Belgium

    Antonio Ventriglia, Belgium

Learn more about the March of Faces

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login